Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02472275
Title	PLX3397, Radiation Therapy, and Antihormone Therapy in Treating Patients With Intermediate- or High-Risk Prostate Cancer
Recruitment	Completed
Gender	male
Phase	Phase I
Variant Requirements	No
Sponsors	Barbara Ann Karmanos Cancer Institute
Indications	prostate adenocarcinoma
Therapies	Leuprolide Pexidartinib Goserelin Degarelix
Age Groups:	adult
Covered Countries	USA

Filter rows:

Showing 1 to 3 of 3 entries

Facility	City	State	Zip	Country	Details
Karmanos Cancer Institute at McLaren Northern Michigan - Petoskey Radiation Oncology	Petoskey	Michigan	49770	United States	Details
Karmanos Cancer Institute at McLaren Northern Michigan- Petoskey Medical Oncology	Petoskey	Michigan	49770	United States	Details
Wayne State University/Karmanos Cancer Institute	Detroit	Michigan	48201	United States	Details

Showing 1 to 3 of 3 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field